--
Related Articles
Research
Jefferies Upgrades Devon Energy to Buy From Hold, Adjusts Price Target to $62 From $53
Devon Energy (DVN) has an average rating of overweight and mean price target of $59.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$DVN
Mining & Metals
Telus Q1 Adjusted Earnings Edge Lower, But Beats Estimates
Telus (T.TO) reported Friday that first-quarter adjusted earnings edged lower but still beat forecasts.Adjusted net income, which most one-time items, contracted 8% to $356 million, or $0.23 per adjusted basic share, from $388 million, or $0.26 per share, in the prior year period. Analysts polled by FactSet had expected $0.22 per share.Consolidated operating revenue and other income edged down 1% to $5.0 billion, from $5.1 billion the year before, missing the $5.06 billion expected by analysts. Telus said higher consolidated service revenue growth of 1% was offset by lower Mobile equipment revenue and other income.The company reported total mobile and fixed customer growth of 262,000 driven by 12,000 mobile phone and 229,000 connected device net additions, along with 21,000 internet customer net additions, during the quarter.As of the end of the first quarter, healthcare lives covered in Telus Health were 169.6 million globally, up 93.1 million year over year. The increase also reflects the addition of 79.3 million lives covered from Telus' acquisition of Workplace Options last May. The company is reviewing strategic partnership opportunities for Telus and will use the proceeds from any monetization for deleveraging, chief executive Darren Entwhistle said.Telus will pay a regular quarterly dividend of $0.4184 per share on July 2, to shareholders of record on June 10.Telus separately announced that chief financial officer Doug French will retire on June 30. Gopi Chande, currently chief financial officer of Telus Digital and Telus Health, will assume the post on July 1. French will continue in an advisory capacity until July 31 and will chair the board of Telus' Terrion tower company.Telus shares were last seen down US$0.06, to US$12.84 in U.S. pre-market trading.
$T.TO
Asia
Market Chatter: Novo Nordisk India Sales Jump 40% in April After Wegovy, Ozempic Price Cuts
Novo Nordisk's diabetes and obesity drug sales recorded a sharp rise in India sales in April after it reduced prices of Wegovy and Ozempic to counter growing competition from generic semaglutide therapies, Bloomberg News reported Friday, citing Pharmarack data.Sales of Wegovy, Ozempic and partner-branded products climbed 40% monthly to 32,000 units in April, which was the first full month since the Danish pharmaceutical group lowered starter-dose prices by up to 48%, the report noted.India's overall GLP-1 market expanded 56% month over month in April to 414,000 units, driven by low-cost generic semaglutide products, the report noted. Eli Lilly remained the country's top-selling GLP-1 drugmaker.Novo Nordisk did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$^BSE$^NSEI